Thank you, Chair.
Thank you to my colleague for bringing the motion.
My understanding as well is that the new drug that it's been replaced with is not as effective as the previous drug, so there is some threat to the patients, the 75 children and young adults who have this condition.
I want to put on record as well that although the special access system is in place, many times even when the doctor authorizes the medication, the special access is being denied by the government. I had an issue with this just this week in my riding. A six-year-old girl who came back from Jamaica returned with hookworm. You may have seen some of this in the paper. There was another fellow. Both were denied. The fellow had to go to the States to get the medication, at huge expense. Fortunately I was able to escalate the issue to the chief health officer, who was able to reverse the decision, but I think there is an issue there in addition to the Cystagon.